Russian scientists at the Krasnoyarsk Research Center and the Siberian Federal University have developed new artificial hybrid proteins that are capable of rapidly pinpointing oncology markers in a patient’s blood.

If cancer is identified, the proteins are said to be able to proactively send out a bioluminescent signal a physician could use to diagnose the case.

Experiments reportedly revealed that the proteins were stable and active enough, and also impervious to negative temperatures.

The new project is expected to lay the foundation for the development of high-accuracy test systems for cancer diagnostics.